Biotech Weekly Recap 4
Big moves in the biotech world!
Vertex Pharmaceuticals #VRTX just got #FDA approval for JOURNAVX (suzetrigine)—the first non-opioid painkiller in 20 years! Vertex also locked in an NHS England deal for #CASGEVY, a gene-edited therapy for sickle cell disease!
We also have upcoming events. First, the Guggenheim SMID Cap #Biotech #Conference is set for February 5-6 in NYC! And on February 24, Novartis’ #NVS FABHALTA (iptacopan) will face an #FDA Advisory Committee #AdCom voting decision for treating C3 glomerulopathy, a rare kidney disease. Could this be the next big approval?
If you are an accredited investor who is passionate about saving lives while growing your investment portfolio, Evergrowth Biohealthcare Capital can be a good fit for you.
▶ SCHEDULE A CALL WITH DR. TRAN:
https://calendly.com/drharveytran/eve...
▶ CONNECT WITH US:
Website: https://evergrowthinvest.com/
Email: [email protected]
LinkedIn: / evergrowth-biohealthcare-capital
Phone: +1(704) 957-7746
▶ CONNECT WITH DR. HARVEY TRAN:
Twitter: / drtranbiosci
LinkedIn: / drharveytran
Email: [email protected]
Disclaimer: As a medical doctor/market expert, I’m not a registered investment advisor. Despite that I strive to provide the most accurate information, I neither guarantee the accuracy nor timeliness. Past performance does NOT guarantee future results. I reserve the right to make any investment decision for myself and my affiliates pertaining to any security without notification except where it is required by law. I am also NOT responsible for the actions of my affiliates. The thesis that I presented may change anytime due to the changing nature of information itself. Investment in stocks and options can result in a loss of capital. The information presented should NOT be construed as a recommendation to buy or sell any form of security. My articles and videos are best utilized as educational and informational materials to assist investors in your own due diligence process. That said, you are expected to perform your own due diligence and take responsibility for your actions. You should also consult with your own financial advisor for specific guidance, as financial circumstances are individualized. That aside, what I shared with you is not professional medical advice. I simply share with you what I share with my own family to help get more out of your life.